<DOC>
	<DOCNO>NCT00589953</DOCNO>
	<brief_summary>The high risk perinatal brain injury occur among extremely premature infant weigh less 1250 gram birth . Such perinatal brain injury currently irreversible , associated neurodevelopmental disability , without adequate treatment modality . Research recent year suggest animal human study erythropoietin ( Epo ) may significant neuroprotective effect . Given historical safe medical profile Epo use anemia prematurity likely need great dosage regimen activation neuroprotective pathway neonatal brain injury , therefore propose phase II study high-dose Epo low birth weight infant prevention and/or attenuation prematurity-related cerebral hemorrhagic-ischemic injury .</brief_summary>
	<brief_title>High-Dose Erythropoietin Extremely Premature Infants Prevent/Attenuate Brain Injury : A Phase II Study</brief_title>
	<detailed_description>Eligible extremely premature infant enrol double-blind , placebo-controlled randomize trial neonatal intensive care unit Morristown Memorial Hospital ( Morristown , New Jersey ) . Subjects enrol within first 24 hour life randomly assign receive Epo saline vehicle placebo . Standard NICU care provide subject . Serial exam , CBC-d , reticulocyte count , serum Epo level , serial HUS , head MRI collect establish time point study period . At 18 22 month correct age , subject undergo neurodevelopmental evaluation assess cerebral palsy , Bayley Scores Infant Development-II ( BSID-II ) Mental Development Index ( MDI ) , BSID-II Psychomotor Development Index ( PDI ) , bilateral hearing aid use , visual impairment .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Leukomalacia , Periventricular</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>500 1250 gram birth Less 32 week gestation birth Less 24 hour life time enrollment Congenital anomaly ( chromosomal , CNS , cardiac , GI , pulmonary ) Seizures within first 24 hour life Severe neutropenia ( ANC &lt; 500 cells/microL ) within first 24 hour life Polycythemia ( Hct &gt; 65 % ) within first 24 hour life Thrombocytopenia ( platelet &lt; 50K cells/microL ) within first 24 hour life Hypertension ( SBP &gt; 100mmHg ) without vasopressor support within first 24 hour life</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Extreme Prematurity</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Perinatal Brain Injury</keyword>
	<keyword>Intraventricular Hemorrhage</keyword>
	<keyword>Periventricular Leukomalacia</keyword>
	<keyword>Neurodevelopmental Outcomes</keyword>
	<keyword>Randomized Clinical Trial</keyword>
</DOC>